Cumberland Pharmaceuticals names new director
20 July 2022 -

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a US-based specialty pharmaceutical company, announced on Tuesday that it has named Martin Brown Jr as its new director.

Brown has served as director of Brown-Forman Corporation. He is an attorney at Adams and Reese LLP. He has around 30 years of legal experience representing privately held businesses, counselling owners in complex business transactions, intellectual property licensing, international commerce, mergers and acquisitions, and estate planning. He has served as director of the parent company of Aegis Sciences Corporation. He is an active board member for many community organisations, including the Land Trust for Tennessee, Nashville Public Radio, Montgomery Bell Academy, Nashville Public Television, Centerstone Mental Health Center, Cheekwood Estate and Gardens, and Tennessee chapter of the Nature Conservancy.

AJ Kazimi, Cumberland Pharmaceuticals CEO and board chairman, said, 'Martin brings tremendous legal, health care and civic experience to Cumberland's board of directors. We are honoured to welcome him to our board and know his contributions will be valuable in supporting our mission to deliver innovative products that address poorly met medical needs.'